 | • レポートコード：MRC308GR01935 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（2-3営業日） • 産業分類：化学＆材料 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の医薬品用ダサチニブの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の医薬品用ダサチニブ市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 医薬品用ダサチニブの成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
医薬品用ダサチニブ市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・純度≧99%、純度<99%
用途別セグメント
・錠剤、その他
主要な市場プレーヤー
・BIOCON LTD、CDYMAX INDIA PHARMA PRIVATE LTD、CIPLA LTD、INTAS PHARMACEUTICALS LTD、GRANULES INDIA LTD、AUROBINDO PHARMA LTD、DR REDDYS LABORATORIES LTD、BIOCARE PHARMACEUTICAL LTD、SUN PHARMACEUTICAL INDUSTRIES LTD、MSN LABORATORIES PRIVATE LTD、TEVA PHARMACEUTICAL INDUSTRIES LTD、HETERO LABS LTD、ALEMBIC PHARMACEUTICALS LTD、RELIANCE LIFE SCIENCES PVT LTD、HIKMA PHARMACEUTICALS LLC、HUBEI HAOSUN PHARMACEUTICAL CO LTD、ALP PHARM BEIJING CO LTD
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、医薬品用ダサチニブ製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な医薬品用ダサチニブメーカーの企業概要、2019年～2022年までの医薬品用ダサチニブの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な医薬品用ダサチニブメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別医薬品用ダサチニブの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの医薬品用ダサチニブの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での医薬品用ダサチニブ市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および医薬品用ダサチニブの産業チェーンを掲載しています。
・第14、15章では、医薬品用ダサチニブの販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
- 医薬品用ダサチニブの概要
- 種類別分析（2018年vs2022年vs2029年）：純度≧99%、純度<99%
- 用途別分析（2018年vs2022年vs2029年）：錠剤、その他
- 世界の医薬品用ダサチニブ市場規模・予測
- 世界の医薬品用ダサチニブ生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- BIOCON LTD、CDYMAX INDIA PHARMA PRIVATE LTD、CIPLA LTD、INTAS PHARMACEUTICALS LTD、GRANULES INDIA LTD、AUROBINDO PHARMA LTD、DR REDDYS LABORATORIES LTD、BIOCARE PHARMACEUTICAL LTD、SUN PHARMACEUTICAL INDUSTRIES LTD、MSN LABORATORIES PRIVATE LTD、TEVA PHARMACEUTICAL INDUSTRIES LTD、HETERO LABS LTD、ALEMBIC PHARMACEUTICALS LTD、RELIANCE LIFE SCIENCES PVT LTD、HIKMA PHARMACEUTICALS LLC、HUBEI HAOSUN PHARMACEUTICAL CO LTD、ALP PHARM BEIJING CO LTD
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：純度≧99%、純度<99%
・用途別分析2018年-2029年：錠剤、その他
・医薬品用ダサチニブの北米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・医薬品用ダサチニブのヨーロッパ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・医薬品用ダサチニブのアジア市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・医薬品用ダサチニブの南米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・医薬品用ダサチニブの中東・アフリカ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Pharmaceutical Grade Dasatinib
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pharmaceutical Grade Dasatinib Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Purity≥99%
1.3.3 Purity<99%
1.4 Market Analysis by Application
1.4.1 Overview: Global Pharmaceutical Grade Dasatinib Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Tablet
1.4.3 Others
1.5 Global Pharmaceutical Grade Dasatinib Market Size & Forecast
1.5.1 Global Pharmaceutical Grade Dasatinib Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pharmaceutical Grade Dasatinib Sales Quantity (2018-2029)
1.5.3 Global Pharmaceutical Grade Dasatinib Average Price (2018-2029)
2 Manufacturers Profiles
2.1 BIOCON LTD
2.1.1 BIOCON LTD Details
2.1.2 BIOCON LTD Major Business
2.1.3 BIOCON LTD Pharmaceutical Grade Dasatinib Product and Services
2.1.4 BIOCON LTD Pharmaceutical Grade Dasatinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 BIOCON LTD Recent Developments/Updates
2.2 CDYMAX INDIA PHARMA PRIVATE LTD
2.2.1 CDYMAX INDIA PHARMA PRIVATE LTD Details
2.2.2 CDYMAX INDIA PHARMA PRIVATE LTD Major Business
2.2.3 CDYMAX INDIA PHARMA PRIVATE LTD Pharmaceutical Grade Dasatinib Product and Services
2.2.4 CDYMAX INDIA PHARMA PRIVATE LTD Pharmaceutical Grade Dasatinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CDYMAX INDIA PHARMA PRIVATE LTD Recent Developments/Updates
2.3 CIPLA LTD
2.3.1 CIPLA LTD Details
2.3.2 CIPLA LTD Major Business
2.3.3 CIPLA LTD Pharmaceutical Grade Dasatinib Product and Services
2.3.4 CIPLA LTD Pharmaceutical Grade Dasatinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 CIPLA LTD Recent Developments/Updates
2.4 INTAS PHARMACEUTICALS LTD
2.4.1 INTAS PHARMACEUTICALS LTD Details
2.4.2 INTAS PHARMACEUTICALS LTD Major Business
2.4.3 INTAS PHARMACEUTICALS LTD Pharmaceutical Grade Dasatinib Product and Services
2.4.4 INTAS PHARMACEUTICALS LTD Pharmaceutical Grade Dasatinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 INTAS PHARMACEUTICALS LTD Recent Developments/Updates
2.5 GRANULES INDIA LTD
2.5.1 GRANULES INDIA LTD Details
2.5.2 GRANULES INDIA LTD Major Business
2.5.3 GRANULES INDIA LTD Pharmaceutical Grade Dasatinib Product and Services
2.5.4 GRANULES INDIA LTD Pharmaceutical Grade Dasatinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 GRANULES INDIA LTD Recent Developments/Updates
2.6 AUROBINDO PHARMA LTD
2.6.1 AUROBINDO PHARMA LTD Details
2.6.2 AUROBINDO PHARMA LTD Major Business
2.6.3 AUROBINDO PHARMA LTD Pharmaceutical Grade Dasatinib Product and Services
2.6.4 AUROBINDO PHARMA LTD Pharmaceutical Grade Dasatinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 AUROBINDO PHARMA LTD Recent Developments/Updates
2.7 DR REDDYS LABORATORIES LTD
2.7.1 DR REDDYS LABORATORIES LTD Details
2.7.2 DR REDDYS LABORATORIES LTD Major Business
2.7.3 DR REDDYS LABORATORIES LTD Pharmaceutical Grade Dasatinib Product and Services
2.7.4 DR REDDYS LABORATORIES LTD Pharmaceutical Grade Dasatinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 DR REDDYS LABORATORIES LTD Recent Developments/Updates
2.8 BIOCARE PHARMACEUTICAL LTD
2.8.1 BIOCARE PHARMACEUTICAL LTD Details
2.8.2 BIOCARE PHARMACEUTICAL LTD Major Business
2.8.3 BIOCARE PHARMACEUTICAL LTD Pharmaceutical Grade Dasatinib Product and Services
2.8.4 BIOCARE PHARMACEUTICAL LTD Pharmaceutical Grade Dasatinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 BIOCARE PHARMACEUTICAL LTD Recent Developments/Updates
2.9 SUN PHARMACEUTICAL INDUSTRIES LTD
2.9.1 SUN PHARMACEUTICAL INDUSTRIES LTD Details
2.9.2 SUN PHARMACEUTICAL INDUSTRIES LTD Major Business
2.9.3 SUN PHARMACEUTICAL INDUSTRIES LTD Pharmaceutical Grade Dasatinib Product and Services
2.9.4 SUN PHARMACEUTICAL INDUSTRIES LTD Pharmaceutical Grade Dasatinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 SUN PHARMACEUTICAL INDUSTRIES LTD Recent Developments/Updates
2.10 MSN LABORATORIES PRIVATE LTD
2.10.1 MSN LABORATORIES PRIVATE LTD Details
2.10.2 MSN LABORATORIES PRIVATE LTD Major Business
2.10.3 MSN LABORATORIES PRIVATE LTD Pharmaceutical Grade Dasatinib Product and Services
2.10.4 MSN LABORATORIES PRIVATE LTD Pharmaceutical Grade Dasatinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 MSN LABORATORIES PRIVATE LTD Recent Developments/Updates
2.11 TEVA PHARMACEUTICAL INDUSTRIES LTD
2.11.1 TEVA PHARMACEUTICAL INDUSTRIES LTD Details
2.11.2 TEVA PHARMACEUTICAL INDUSTRIES LTD Major Business
2.11.3 TEVA PHARMACEUTICAL INDUSTRIES LTD Pharmaceutical Grade Dasatinib Product and Services
2.11.4 TEVA PHARMACEUTICAL INDUSTRIES LTD Pharmaceutical Grade Dasatinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 TEVA PHARMACEUTICAL INDUSTRIES LTD Recent Developments/Updates
2.12 HETERO LABS LTD
2.12.1 HETERO LABS LTD Details
2.12.2 HETERO LABS LTD Major Business
2.12.3 HETERO LABS LTD Pharmaceutical Grade Dasatinib Product and Services
2.12.4 HETERO LABS LTD Pharmaceutical Grade Dasatinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 HETERO LABS LTD Recent Developments/Updates
2.13 ALEMBIC PHARMACEUTICALS LTD
2.13.1 ALEMBIC PHARMACEUTICALS LTD Details
2.13.2 ALEMBIC PHARMACEUTICALS LTD Major Business
2.13.3 ALEMBIC PHARMACEUTICALS LTD Pharmaceutical Grade Dasatinib Product and Services
2.13.4 ALEMBIC PHARMACEUTICALS LTD Pharmaceutical Grade Dasatinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 ALEMBIC PHARMACEUTICALS LTD Recent Developments/Updates
2.14 RELIANCE LIFE SCIENCES PVT LTD
2.14.1 RELIANCE LIFE SCIENCES PVT LTD Details
2.14.2 RELIANCE LIFE SCIENCES PVT LTD Major Business
2.14.3 RELIANCE LIFE SCIENCES PVT LTD Pharmaceutical Grade Dasatinib Product and Services
2.14.4 RELIANCE LIFE SCIENCES PVT LTD Pharmaceutical Grade Dasatinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 RELIANCE LIFE SCIENCES PVT LTD Recent Developments/Updates
2.15 HIKMA PHARMACEUTICALS LLC
2.15.1 HIKMA PHARMACEUTICALS LLC Details
2.15.2 HIKMA PHARMACEUTICALS LLC Major Business
2.15.3 HIKMA PHARMACEUTICALS LLC Pharmaceutical Grade Dasatinib Product and Services
2.15.4 HIKMA PHARMACEUTICALS LLC Pharmaceutical Grade Dasatinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 HIKMA PHARMACEUTICALS LLC Recent Developments/Updates
2.16 HUBEI HAOSUN PHARMACEUTICAL CO LTD
2.16.1 HUBEI HAOSUN PHARMACEUTICAL CO LTD Details
2.16.2 HUBEI HAOSUN PHARMACEUTICAL CO LTD Major Business
2.16.3 HUBEI HAOSUN PHARMACEUTICAL CO LTD Pharmaceutical Grade Dasatinib Product and Services
2.16.4 HUBEI HAOSUN PHARMACEUTICAL CO LTD Pharmaceutical Grade Dasatinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 HUBEI HAOSUN PHARMACEUTICAL CO LTD Recent Developments/Updates
2.17 ALP PHARM BEIJING CO LTD
2.17.1 ALP PHARM BEIJING CO LTD Details
2.17.2 ALP PHARM BEIJING CO LTD Major Business
2.17.3 ALP PHARM BEIJING CO LTD Pharmaceutical Grade Dasatinib Product and Services
2.17.4 ALP PHARM BEIJING CO LTD Pharmaceutical Grade Dasatinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 ALP PHARM BEIJING CO LTD Recent Developments/Updates
3 Competitive Environment: Pharmaceutical Grade Dasatinib by Manufacturer
3.1 Global Pharmaceutical Grade Dasatinib Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pharmaceutical Grade Dasatinib Revenue by Manufacturer (2018-2023)
3.3 Global Pharmaceutical Grade Dasatinib Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pharmaceutical Grade Dasatinib by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pharmaceutical Grade Dasatinib Manufacturer Market Share in 2022
3.4.2 Top 6 Pharmaceutical Grade Dasatinib Manufacturer Market Share in 2022
3.5 Pharmaceutical Grade Dasatinib Market: Overall Company Footprint Analysis
3.5.1 Pharmaceutical Grade Dasatinib Market: Region Footprint
3.5.2 Pharmaceutical Grade Dasatinib Market: Company Product Type Footprint
3.5.3 Pharmaceutical Grade Dasatinib Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pharmaceutical Grade Dasatinib Market Size by Region
4.1.1 Global Pharmaceutical Grade Dasatinib Sales Quantity by Region (2018-2029)
4.1.2 Global Pharmaceutical Grade Dasatinib Consumption Value by Region (2018-2029)
4.1.3 Global Pharmaceutical Grade Dasatinib Average Price by Region (2018-2029)
4.2 North America Pharmaceutical Grade Dasatinib Consumption Value (2018-2029)
4.3 Europe Pharmaceutical Grade Dasatinib Consumption Value (2018-2029)
4.4 Asia-Pacific Pharmaceutical Grade Dasatinib Consumption Value (2018-2029)
4.5 South America Pharmaceutical Grade Dasatinib Consumption Value (2018-2029)
4.6 Middle East and Africa Pharmaceutical Grade Dasatinib Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Pharmaceutical Grade Dasatinib Sales Quantity by Type (2018-2029)
5.2 Global Pharmaceutical Grade Dasatinib Consumption Value by Type (2018-2029)
5.3 Global Pharmaceutical Grade Dasatinib Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Pharmaceutical Grade Dasatinib Sales Quantity by Application (2018-2029)
6.2 Global Pharmaceutical Grade Dasatinib Consumption Value by Application (2018-2029)
6.3 Global Pharmaceutical Grade Dasatinib Average Price by Application (2018-2029)
7 North America
7.1 North America Pharmaceutical Grade Dasatinib Sales Quantity by Type (2018-2029)
7.2 North America Pharmaceutical Grade Dasatinib Sales Quantity by Application (2018-2029)
7.3 North America Pharmaceutical Grade Dasatinib Market Size by Country
7.3.1 North America Pharmaceutical Grade Dasatinib Sales Quantity by Country (2018-2029)
7.3.2 North America Pharmaceutical Grade Dasatinib Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Pharmaceutical Grade Dasatinib Sales Quantity by Type (2018-2029)
8.2 Europe Pharmaceutical Grade Dasatinib Sales Quantity by Application (2018-2029)
8.3 Europe Pharmaceutical Grade Dasatinib Market Size by Country
8.3.1 Europe Pharmaceutical Grade Dasatinib Sales Quantity by Country (2018-2029)
8.3.2 Europe Pharmaceutical Grade Dasatinib Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Pharmaceutical Grade Dasatinib Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pharmaceutical Grade Dasatinib Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Pharmaceutical Grade Dasatinib Market Size by Region
9.3.1 Asia-Pacific Pharmaceutical Grade Dasatinib Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pharmaceutical Grade Dasatinib Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Pharmaceutical Grade Dasatinib Sales Quantity by Type (2018-2029)
10.2 South America Pharmaceutical Grade Dasatinib Sales Quantity by Application (2018-2029)
10.3 South America Pharmaceutical Grade Dasatinib Market Size by Country
10.3.1 South America Pharmaceutical Grade Dasatinib Sales Quantity by Country (2018-2029)
10.3.2 South America Pharmaceutical Grade Dasatinib Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Pharmaceutical Grade Dasatinib Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pharmaceutical Grade Dasatinib Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Pharmaceutical Grade Dasatinib Market Size by Country
11.3.1 Middle East & Africa Pharmaceutical Grade Dasatinib Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pharmaceutical Grade Dasatinib Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Pharmaceutical Grade Dasatinib Market Drivers
12.2 Pharmaceutical Grade Dasatinib Market Restraints
12.3 Pharmaceutical Grade Dasatinib Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Pharmaceutical Grade Dasatinib and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pharmaceutical Grade Dasatinib
13.3 Pharmaceutical Grade Dasatinib Production Process
13.4 Pharmaceutical Grade Dasatinib Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pharmaceutical Grade Dasatinib Typical Distributors
14.3 Pharmaceutical Grade Dasatinib Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Pharmaceutical Grade Dasatinib Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pharmaceutical Grade Dasatinib Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. BIOCON LTD Basic Information, Manufacturing Base and Competitors
Table 4. BIOCON LTD Major Business
Table 5. BIOCON LTD Pharmaceutical Grade Dasatinib Product and Services
Table 6. BIOCON LTD Pharmaceutical Grade Dasatinib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. BIOCON LTD Recent Developments/Updates
Table 8. CDYMAX INDIA PHARMA PRIVATE LTD Basic Information, Manufacturing Base and Competitors
Table 9. CDYMAX INDIA PHARMA PRIVATE LTD Major Business
Table 10. CDYMAX INDIA PHARMA PRIVATE LTD Pharmaceutical Grade Dasatinib Product and Services
Table 11. CDYMAX INDIA PHARMA PRIVATE LTD Pharmaceutical Grade Dasatinib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. CDYMAX INDIA PHARMA PRIVATE LTD Recent Developments/Updates
Table 13. CIPLA LTD Basic Information, Manufacturing Base and Competitors
Table 14. CIPLA LTD Major Business
Table 15. CIPLA LTD Pharmaceutical Grade Dasatinib Product and Services
Table 16. CIPLA LTD Pharmaceutical Grade Dasatinib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. CIPLA LTD Recent Developments/Updates
Table 18. INTAS PHARMACEUTICALS LTD Basic Information, Manufacturing Base and Competitors
Table 19. INTAS PHARMACEUTICALS LTD Major Business
Table 20. INTAS PHARMACEUTICALS LTD Pharmaceutical Grade Dasatinib Product and Services
Table 21. INTAS PHARMACEUTICALS LTD Pharmaceutical Grade Dasatinib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. INTAS PHARMACEUTICALS LTD Recent Developments/Updates
Table 23. GRANULES INDIA LTD Basic Information, Manufacturing Base and Competitors
Table 24. GRANULES INDIA LTD Major Business
Table 25. GRANULES INDIA LTD Pharmaceutical Grade Dasatinib Product and Services
Table 26. GRANULES INDIA LTD Pharmaceutical Grade Dasatinib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. GRANULES INDIA LTD Recent Developments/Updates
Table 28. AUROBINDO PHARMA LTD Basic Information, Manufacturing Base and Competitors
Table 29. AUROBINDO PHARMA LTD Major Business
Table 30. AUROBINDO PHARMA LTD Pharmaceutical Grade Dasatinib Product and Services
Table 31. AUROBINDO PHARMA LTD Pharmaceutical Grade Dasatinib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. AUROBINDO PHARMA LTD Recent Developments/Updates
Table 33. DR REDDYS LABORATORIES LTD Basic Information, Manufacturing Base and Competitors
Table 34. DR REDDYS LABORATORIES LTD Major Business
Table 35. DR REDDYS LABORATORIES LTD Pharmaceutical Grade Dasatinib Product and Services
Table 36. DR REDDYS LABORATORIES LTD Pharmaceutical Grade Dasatinib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. DR REDDYS LABORATORIES LTD Recent Developments/Updates
Table 38. BIOCARE PHARMACEUTICAL LTD Basic Information, Manufacturing Base and Competitors
Table 39. BIOCARE PHARMACEUTICAL LTD Major Business
Table 40. BIOCARE PHARMACEUTICAL LTD Pharmaceutical Grade Dasatinib Product and Services
Table 41. BIOCARE PHARMACEUTICAL LTD Pharmaceutical Grade Dasatinib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. BIOCARE PHARMACEUTICAL LTD Recent Developments/Updates
Table 43. SUN PHARMACEUTICAL INDUSTRIES LTD Basic Information, Manufacturing Base and Competitors
Table 44. SUN PHARMACEUTICAL INDUSTRIES LTD Major Business
Table 45. SUN PHARMACEUTICAL INDUSTRIES LTD Pharmaceutical Grade Dasatinib Product and Services
Table 46. SUN PHARMACEUTICAL INDUSTRIES LTD Pharmaceutical Grade Dasatinib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. SUN PHARMACEUTICAL INDUSTRIES LTD Recent Developments/Updates
Table 48. MSN LABORATORIES PRIVATE LTD Basic Information, Manufacturing Base and Competitors
Table 49. MSN LABORATORIES PRIVATE LTD Major Business
Table 50. MSN LABORATORIES PRIVATE LTD Pharmaceutical Grade Dasatinib Product and Services
Table 51. MSN LABORATORIES PRIVATE LTD Pharmaceutical Grade Dasatinib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. MSN LABORATORIES PRIVATE LTD Recent Developments/Updates
Table 53. TEVA PHARMACEUTICAL INDUSTRIES LTD Basic Information, Manufacturing Base and Competitors
Table 54. TEVA PHARMACEUTICAL INDUSTRIES LTD Major Business
Table 55. TEVA PHARMACEUTICAL INDUSTRIES LTD Pharmaceutical Grade Dasatinib Product and Services
Table 56. TEVA PHARMACEUTICAL INDUSTRIES LTD Pharmaceutical Grade Dasatinib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. TEVA PHARMACEUTICAL INDUSTRIES LTD Recent Developments/Updates
Table 58. HETERO LABS LTD Basic Information, Manufacturing Base and Competitors
Table 59. HETERO LABS LTD Major Business
Table 60. HETERO LABS LTD Pharmaceutical Grade Dasatinib Product and Services
Table 61. HETERO LABS LTD Pharmaceutical Grade Dasatinib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. HETERO LABS LTD Recent Developments/Updates
Table 63. ALEMBIC PHARMACEUTICALS LTD Basic Information, Manufacturing Base and Competitors
Table 64. ALEMBIC PHARMACEUTICALS LTD Major Business
Table 65. ALEMBIC PHARMACEUTICALS LTD Pharmaceutical Grade Dasatinib Product and Services
Table 66. ALEMBIC PHARMACEUTICALS LTD Pharmaceutical Grade Dasatinib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. ALEMBIC PHARMACEUTICALS LTD Recent Developments/Updates
Table 68. RELIANCE LIFE SCIENCES PVT LTD Basic Information, Manufacturing Base and Competitors
Table 69. RELIANCE LIFE SCIENCES PVT LTD Major Business
Table 70. RELIANCE LIFE SCIENCES PVT LTD Pharmaceutical Grade Dasatinib Product and Services
Table 71. RELIANCE LIFE SCIENCES PVT LTD Pharmaceutical Grade Dasatinib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. RELIANCE LIFE SCIENCES PVT LTD Recent Developments/Updates
Table 73. HIKMA PHARMACEUTICALS LLC Basic Information, Manufacturing Base and Competitors
Table 74. HIKMA PHARMACEUTICALS LLC Major Business
Table 75. HIKMA PHARMACEUTICALS LLC Pharmaceutical Grade Dasatinib Product and Services
Table 76. HIKMA PHARMACEUTICALS LLC Pharmaceutical Grade Dasatinib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. HIKMA PHARMACEUTICALS LLC Recent Developments/Updates
Table 78. HUBEI HAOSUN PHARMACEUTICAL CO LTD Basic Information, Manufacturing Base and Competitors
Table 79. HUBEI HAOSUN PHARMACEUTICAL CO LTD Major Business
Table 80. HUBEI HAOSUN PHARMACEUTICAL CO LTD Pharmaceutical Grade Dasatinib Product and Services
Table 81. HUBEI HAOSUN PHARMACEUTICAL CO LTD Pharmaceutical Grade Dasatinib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. HUBEI HAOSUN PHARMACEUTICAL CO LTD Recent Developments/Updates
Table 83. ALP PHARM BEIJING CO LTD Basic Information, Manufacturing Base and Competitors
Table 84. ALP PHARM BEIJING CO LTD Major Business
Table 85. ALP PHARM BEIJING CO LTD Pharmaceutical Grade Dasatinib Product and Services
Table 86. ALP PHARM BEIJING CO LTD Pharmaceutical Grade Dasatinib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. ALP PHARM BEIJING CO LTD Recent Developments/Updates
Table 88. Global Pharmaceutical Grade Dasatinib Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 89. Global Pharmaceutical Grade Dasatinib Revenue by Manufacturer (2018-2023) & (USD Million)
Table 90. Global Pharmaceutical Grade Dasatinib Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 91. Market Position of Manufacturers in Pharmaceutical Grade Dasatinib, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 92. Head Office and Pharmaceutical Grade Dasatinib Production Site of Key Manufacturer
Table 93. Pharmaceutical Grade Dasatinib Market: Company Product Type Footprint
Table 94. Pharmaceutical Grade Dasatinib Market: Company Product Application Footprint
Table 95. Pharmaceutical Grade Dasatinib New Market Entrants and Barriers to Market Entry
Table 96. Pharmaceutical Grade Dasatinib Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global Pharmaceutical Grade Dasatinib Sales Quantity by Region (2018-2023) & (Tons)
Table 98. Global Pharmaceutical Grade Dasatinib Sales Quantity by Region (2024-2029) & (Tons)
Table 99. Global Pharmaceutical Grade Dasatinib Consumption Value by Region (2018-2023) & (USD Million)
Table 100. Global Pharmaceutical Grade Dasatinib Consumption Value by Region (2024-2029) & (USD Million)
Table 101. Global Pharmaceutical Grade Dasatinib Average Price by Region (2018-2023) & (US$/Ton)
Table 102. Global Pharmaceutical Grade Dasatinib Average Price by Region (2024-2029) & (US$/Ton)
Table 103. Global Pharmaceutical Grade Dasatinib Sales Quantity by Type (2018-2023) & (Tons)
Table 104. Global Pharmaceutical Grade Dasatinib Sales Quantity by Type (2024-2029) & (Tons)
Table 105. Global Pharmaceutical Grade Dasatinib Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Global Pharmaceutical Grade Dasatinib Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Global Pharmaceutical Grade Dasatinib Average Price by Type (2018-2023) & (US$/Ton)
Table 108. Global Pharmaceutical Grade Dasatinib Average Price by Type (2024-2029) & (US$/Ton)
Table 109. Global Pharmaceutical Grade Dasatinib Sales Quantity by Application (2018-2023) & (Tons)
Table 110. Global Pharmaceutical Grade Dasatinib Sales Quantity by Application (2024-2029) & (Tons)
Table 111. Global Pharmaceutical Grade Dasatinib Consumption Value by Application (2018-2023) & (USD Million)
Table 112. Global Pharmaceutical Grade Dasatinib Consumption Value by Application (2024-2029) & (USD Million)
Table 113. Global Pharmaceutical Grade Dasatinib Average Price by Application (2018-2023) & (US$/Ton)
Table 114. Global Pharmaceutical Grade Dasatinib Average Price by Application (2024-2029) & (US$/Ton)
Table 115. North America Pharmaceutical Grade Dasatinib Sales Quantity by Type (2018-2023) & (Tons)
Table 116. North America Pharmaceutical Grade Dasatinib Sales Quantity by Type (2024-2029) & (Tons)
Table 117. North America Pharmaceutical Grade Dasatinib Sales Quantity by Application (2018-2023) & (Tons)
Table 118. North America Pharmaceutical Grade Dasatinib Sales Quantity by Application (2024-2029) & (Tons)
Table 119. North America Pharmaceutical Grade Dasatinib Sales Quantity by Country (2018-2023) & (Tons)
Table 120. North America Pharmaceutical Grade Dasatinib Sales Quantity by Country (2024-2029) & (Tons)
Table 121. North America Pharmaceutical Grade Dasatinib Consumption Value by Country (2018-2023) & (USD Million)
Table 122. North America Pharmaceutical Grade Dasatinib Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Europe Pharmaceutical Grade Dasatinib Sales Quantity by Type (2018-2023) & (Tons)
Table 124. Europe Pharmaceutical Grade Dasatinib Sales Quantity by Type (2024-2029) & (Tons)
Table 125. Europe Pharmaceutical Grade Dasatinib Sales Quantity by Application (2018-2023) & (Tons)
Table 126. Europe Pharmaceutical Grade Dasatinib Sales Quantity by Application (2024-2029) & (Tons)
Table 127. Europe Pharmaceutical Grade Dasatinib Sales Quantity by Country (2018-2023) & (Tons)
Table 128. Europe Pharmaceutical Grade Dasatinib Sales Quantity by Country (2024-2029) & (Tons)
Table 129. Europe Pharmaceutical Grade Dasatinib Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe Pharmaceutical Grade Dasatinib Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific Pharmaceutical Grade Dasatinib Sales Quantity by Type (2018-2023) & (Tons)
Table 132. Asia-Pacific Pharmaceutical Grade Dasatinib Sales Quantity by Type (2024-2029) & (Tons)
Table 133. Asia-Pacific Pharmaceutical Grade Dasatinib Sales Quantity by Application (2018-2023) & (Tons)
Table 134. Asia-Pacific Pharmaceutical Grade Dasatinib Sales Quantity by Application (2024-2029) & (Tons)
Table 135. Asia-Pacific Pharmaceutical Grade Dasatinib Sales Quantity by Region (2018-2023) & (Tons)
Table 136. Asia-Pacific Pharmaceutical Grade Dasatinib Sales Quantity by Region (2024-2029) & (Tons)
Table 137. Asia-Pacific Pharmaceutical Grade Dasatinib Consumption Value by Region (2018-2023) & (USD Million)
Table 138. Asia-Pacific Pharmaceutical Grade Dasatinib Consumption Value by Region (2024-2029) & (USD Million)
Table 139. South America Pharmaceutical Grade Dasatinib Sales Quantity by Type (2018-2023) & (Tons)
Table 140. South America Pharmaceutical Grade Dasatinib Sales Quantity by Type (2024-2029) & (Tons)
Table 141. South America Pharmaceutical Grade Dasatinib Sales Quantity by Application (2018-2023) & (Tons)
Table 142. South America Pharmaceutical Grade Dasatinib Sales Quantity by Application (2024-2029) & (Tons)
Table 143. South America Pharmaceutical Grade Dasatinib Sales Quantity by Country (2018-2023) & (Tons)
Table 144. South America Pharmaceutical Grade Dasatinib Sales Quantity by Country (2024-2029) & (Tons)
Table 145. South America Pharmaceutical Grade Dasatinib Consumption Value by Country (2018-2023) & (USD Million)
Table 146. South America Pharmaceutical Grade Dasatinib Consumption Value by Country (2024-2029) & (USD Million)
Table 147. Middle East & Africa Pharmaceutical Grade Dasatinib Sales Quantity by Type (2018-2023) & (Tons)
Table 148. Middle East & Africa Pharmaceutical Grade Dasatinib Sales Quantity by Type (2024-2029) & (Tons)
Table 149. Middle East & Africa Pharmaceutical Grade Dasatinib Sales Quantity by Application (2018-2023) & (Tons)
Table 150. Middle East & Africa Pharmaceutical Grade Dasatinib Sales Quantity by Application (2024-2029) & (Tons)
Table 151. Middle East & Africa Pharmaceutical Grade Dasatinib Sales Quantity by Region (2018-2023) & (Tons)
Table 152. Middle East & Africa Pharmaceutical Grade Dasatinib Sales Quantity by Region (2024-2029) & (Tons)
Table 153. Middle East & Africa Pharmaceutical Grade Dasatinib Consumption Value by Region (2018-2023) & (USD Million)
Table 154. Middle East & Africa Pharmaceutical Grade Dasatinib Consumption Value by Region (2024-2029) & (USD Million)
Table 155. Pharmaceutical Grade Dasatinib Raw Material
Table 156. Key Manufacturers of Pharmaceutical Grade Dasatinib Raw Materials
Table 157. Pharmaceutical Grade Dasatinib Typical Distributors
Table 158. Pharmaceutical Grade Dasatinib Typical Customers
List of Figures
Figure 1. Pharmaceutical Grade Dasatinib Picture
Figure 2. Global Pharmaceutical Grade Dasatinib Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pharmaceutical Grade Dasatinib Consumption Value Market Share by Type in 2022
Figure 4. Purity≥99% Examples
Figure 5. Purity<99% Examples
Figure 6. Global Pharmaceutical Grade Dasatinib Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Pharmaceutical Grade Dasatinib Consumption Value Market Share by Application in 2022
Figure 8. Tablet Examples
Figure 9. Others Examples
Figure 10. Global Pharmaceutical Grade Dasatinib Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Pharmaceutical Grade Dasatinib Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Pharmaceutical Grade Dasatinib Sales Quantity (2018-2029) & (Tons)
Figure 13. Global Pharmaceutical Grade Dasatinib Average Price (2018-2029) & (US$/Ton)
Figure 14. Global Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Pharmaceutical Grade Dasatinib Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Pharmaceutical Grade Dasatinib by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Pharmaceutical Grade Dasatinib Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Pharmaceutical Grade Dasatinib Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Pharmaceutical Grade Dasatinib Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Pharmaceutical Grade Dasatinib Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Pharmaceutical Grade Dasatinib Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Pharmaceutical Grade Dasatinib Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Pharmaceutical Grade Dasatinib Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Pharmaceutical Grade Dasatinib Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Pharmaceutical Grade Dasatinib Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Pharmaceutical Grade Dasatinib Average Price by Type (2018-2029) & (US$/Ton)
Figure 29. Global Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Pharmaceutical Grade Dasatinib Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Pharmaceutical Grade Dasatinib Average Price by Application (2018-2029) & (US$/Ton)
Figure 32. North America Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Pharmaceutical Grade Dasatinib Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Pharmaceutical Grade Dasatinib Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Pharmaceutical Grade Dasatinib Consumption Value Market Share by Region (2018-2029)
Figure 52. China Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Pharmaceutical Grade Dasatinib Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Pharmaceutical Grade Dasatinib Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Pharmaceutical Grade Dasatinib Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Pharmaceutical Grade Dasatinib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Pharmaceutical Grade Dasatinib Market Drivers
Figure 73. Pharmaceutical Grade Dasatinib Market Restraints
Figure 74. Pharmaceutical Grade Dasatinib Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Pharmaceutical Grade Dasatinib in 2022
Figure 77. Manufacturing Process Analysis of Pharmaceutical Grade Dasatinib
Figure 78. Pharmaceutical Grade Dasatinib Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source